Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Buy JSPR Stock  Free JSPR Stock Alerts

Jasper Therapeutics (JSPR) SEC Filings & 10K Form

Jasper Therapeutics logo
$4.46 -0.38 (-7.85%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$4.55 +0.09 (+2.02%)
As of 03/28/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Jasper Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/26/2025
11:15 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form EFFECT
03/26/2025
3:52 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 424B5
03/19/2025
3:42 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
3:11 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2025
8:20 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
7:05 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
6:05 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
7:02 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
7:02 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:01 PM		Avidity Partners Management LP (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Form SC 13G/A
11/07/2024
6:42 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:30 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
11:05 AM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Form SC 13G
10/15/2024
5:03 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:18 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
4:19 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
6:00 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
5:02 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:05 AM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lucas Svetlana (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
5:07 AM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:40 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:31 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
7:00 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:25 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Shizuru Judith Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:28 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Nolet Chris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:30 PM		French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:31 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:15 PM		EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:17 PM		Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:20 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:24 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:01 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
06/07/2024
4:04 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
06/07/2024
4:07 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
05/14/2024
12:53 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
5:07 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEFA14A
04/22/2024
12:53 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form ARS
04/22/2024
12:37 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEFA14A
04/22/2024
12:13 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:JSPR) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...
Chaikin Analytics | Sponsored
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
The Dirty Secret About Gold Mining Stocks...
Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...
Golden Portfolio | Sponsored